Compare Charles River Laboratories Intl. Inc (CRL) vs Nebius Group NV (NBIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Nebius Group NV — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Nebius Group NV trades at $221.12 (market cap $59.73B). The key difference: Nebius Group NV is far larger — about 4.2× Charles River Laboratories Intl. Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Nebius Group NV nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Nebius Group NV for 24 Days on average.
| CRL | NBIS | |
|---|---|---|
Market Cap | $14.23B | $59.73B |
Volume | 1,176,885 | 21,563,700 |
Sector | Health | Technology |
52-Week High | $310.77 | $286.69 |
52-Week Low | $149.93 | $73.87 |
Typical Hold Time | 33 Days | 24 Days |
Enterprise Value | $17.06B | $61.86B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298, down 0.77% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus price target. The stock maintains a bullish technical outlook with support at $292 and resistance at $301, while recent earnings have consistently beaten expectations despite negative net income margins. The company's 2026 Investor Day highlighted a strategic vision targeting 5-7% organic growth and $300 million in savings by 2030.
CRL presents a compelling growth story with solid operational cash flow and strategic initiatives, though investors face risks from negative profitability metrics and elevated valuation multiples. The stock's current position near analyst targets suggests limited upside without improved earnings execution, while ongoing margin pressures and debt levels require careful monitoring amid the company's transformation efforts.
NBIS trades at $219.71, down 7.32% today amid bearish technical signals, though recent quarterly earnings beat expectations. The company shows strong revenue growth with $530M in 2025 and $1.4B projected for 2026, but profitability remains challenged with a net margin of 3.13%. Analyst consensus is strongly bullish with 82% buy ratings and a $288.67 price target, representing 31% upside potential from current levels.
The stock presents significant growth potential driven by AI infrastructure demand and billion-dollar partnerships with Meta and Nvidia, but faces execution risks from aggressive expansion spending and high valuation multiples. Competitive pressures and insider selling activity warrant caution despite the compelling growth narrative in the AI cloud sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →
